Kim Solez Transition transplant path to tissue engineering path new banff
-
Upload
kim-solez- -
Category
Health & Medicine
-
view
93 -
download
2
Transcript of Kim Solez Transition transplant path to tissue engineering path new banff
![Page 1: Kim Solez Transition transplant path to tissue engineering path new banff](https://reader036.fdocuments.us/reader036/viewer/2022081520/587f6d081a28ab9b398b72e7/html5/thumbnails/1.jpg)
The Transition Between Transplant Pathology and
Tissue Engineering Pathology: Beginning A New
Banff ClassificationKim Solez, MD
![Page 2: Kim Solez Transition transplant path to tissue engineering path new banff](https://reader036.fdocuments.us/reader036/viewer/2022081520/587f6d081a28ab9b398b72e7/html5/thumbnails/2.jpg)
Stem Cell Technologies on Google Trends – News Headlines and Forecast
![Page 3: Kim Solez Transition transplant path to tissue engineering path new banff](https://reader036.fdocuments.us/reader036/viewer/2022081520/587f6d081a28ab9b398b72e7/html5/thumbnails/3.jpg)
Current transplant protocols reach fewer than 10% of those in need.
![Page 4: Kim Solez Transition transplant path to tissue engineering path new banff](https://reader036.fdocuments.us/reader036/viewer/2022081520/587f6d081a28ab9b398b72e7/html5/thumbnails/4.jpg)
Worldwide 1.2 million people are in need of transplantation for end stage organ failure. Current transplant protocols reach fewer than 10% of this number. Regenerative medicine can save the remaining 90%, over one million people annually!
![Page 5: Kim Solez Transition transplant path to tissue engineering path new banff](https://reader036.fdocuments.us/reader036/viewer/2022081520/587f6d081a28ab9b398b72e7/html5/thumbnails/5.jpg)
Tissue engineered bladder.
Regenerative Medicine Already Here! Working for Tubular Organs, Bladder, Trachea, Esophagus, Vagina.
![Page 6: Kim Solez Transition transplant path to tissue engineering path new banff](https://reader036.fdocuments.us/reader036/viewer/2022081520/587f6d081a28ab9b398b72e7/html5/thumbnails/6.jpg)
https://3dprintingindustry.com/news/organovo-3d-bioprinted-liver-tissue-make-fda-2019-101775/
Regenerative Medicine Already Here! 3D printed Liver Tissue May Be Ready for FDA approval in 2019.
![Page 7: Kim Solez Transition transplant path to tissue engineering path new banff](https://reader036.fdocuments.us/reader036/viewer/2022081520/587f6d081a28ab9b398b72e7/html5/thumbnails/7.jpg)
ViaCyte Announces Highly Anticipated Encapsulation Clinical
Trial Site Expansion into Canada JDRF-funded researcher, Dr. James Shapiro
will be the lead investigator at the Canadian site. TORONTO, July 29, 2015 -- ViaCyte, Inc. announced the opening of a second site in its Phase 1/2 trial for Type I Diabetes which utilizes PEC-01™ pancreatic progenitor cells and the proprietary Encaptra® drug delivery system which is designed to protect the transplanted cells from a patient’s immune system.
Regenerative Medicine Already Here! Viacyte Trial for Diabetes Therapy.
![Page 8: Kim Solez Transition transplant path to tissue engineering path new banff](https://reader036.fdocuments.us/reader036/viewer/2022081520/587f6d081a28ab9b398b72e7/html5/thumbnails/8.jpg)
Double Think: Stem Cells are Greatest Hope and Greatest Hype, Stem Cell Tourism Estimated to be $3 Billion a Year Industry and Growing, with More than 700 Clinics Worldwide
Mason C et al. Regen Med. 2011 May;6(3):265-72. doi: 10.2217/rme.11.28. Cell therapy industry: billion dollar global business with unlimited potential.
Timothy Caulfield - Stem Cell Tourism June 2015https://www.youtube.com/watch?v=B0r89nMtg10
![Page 9: Kim Solez Transition transplant path to tissue engineering path new banff](https://reader036.fdocuments.us/reader036/viewer/2022081520/587f6d081a28ab9b398b72e7/html5/thumbnails/9.jpg)
University of Alberta Health Law Institutehttp://www.hli.ualberta.ca/en/Publications.aspx Stem cell Publications
Science, Celebrities, and Public EngagementTimothy Caulfield and Declan Fahy on Science, Celebrities, and Public Engagement in the Summer 2016 Issues in Science and Technology. www.issues.org JUNE 16, 2016
Science: Confronting stem cell hypeProfessor Timothy Caulfield co-authors new stem cell policy guidelines.MAY 13, 2016
![Page 10: Kim Solez Transition transplant path to tissue engineering path new banff](https://reader036.fdocuments.us/reader036/viewer/2022081520/587f6d081a28ab9b398b72e7/html5/thumbnails/10.jpg)
University of Alberta Health Law Institutehttp://www.hli.ualberta.ca/en/Publications.aspx Stem cell Publications
Science: Confronting stem cell hypeProfessor Timothy Caulfield co-authors new stem cell policy guidelines.MAY 13, 2016
Stem cell hype: Media portrayal of therapy translationMARCH 30, 2015
Policy Options: Athletes and unproven stem cell therapiesJANUARY 01, 2015
![Page 11: Kim Solez Transition transplant path to tissue engineering path new banff](https://reader036.fdocuments.us/reader036/viewer/2022081520/587f6d081a28ab9b398b72e7/html5/thumbnails/11.jpg)
University of Alberta Health Law Institutehttp://www.hli.ualberta.ca/en/Publications.aspx Stem cell publications continued
Research ethics and stem cells Is it time to re‐think current approaches to oversight?DECEMBER 04, 2014Representations of Stem Cell Clinics on TwitterDECEMBER 01, 2014 Unproven stem cell-based interventions & physicians' professional obligations; a qualitative study with medical regulatory authorities in Canada.OCTOBER 14, 2014 Professional Regulation: A Potentially Valuable Tool in Responding to "Stem Cell Tourism"SEPTEMBER 09, 2014
![Page 12: Kim Solez Transition transplant path to tissue engineering path new banff](https://reader036.fdocuments.us/reader036/viewer/2022081520/587f6d081a28ab9b398b72e7/html5/thumbnails/12.jpg)
University of Alberta Health Law Institutehttp://www.hli.ualberta.ca/en/Publications.aspx Stem cell publications continued
Stem Cell Tourism and Public Education: The Missing ElementsSEPTEMBER 04, 2014 Policy recommendations for addressing privacy challenges associated with cell-based research and interventionsFEBRUARY 03, 2014 Commercialization and Stem Cell Research: A Review of Emerging IssuesDECEMBER 20, 2013A Role for Patient Advocacy Groups in Countering the Premature Commercialization of Stem Cell InterventionsOCTOBER 01, 2013
![Page 13: Kim Solez Transition transplant path to tissue engineering path new banff](https://reader036.fdocuments.us/reader036/viewer/2022081520/587f6d081a28ab9b398b72e7/html5/thumbnails/13.jpg)
The Positive Aspects of Stem Cell Therapies,The True Hope, Has Potential to Reverse Three Looming Problems in Medicine:
1. The loss of “luster” in transplantation.2. Workforce problems in nephrology due to lack of appeal to young people/potential trainees worldwide.
3. Technological unemployment in medicine due to replacement of human workers by machines.
![Page 14: Kim Solez Transition transplant path to tissue engineering path new banff](https://reader036.fdocuments.us/reader036/viewer/2022081520/587f6d081a28ab9b398b72e7/html5/thumbnails/14.jpg)
“They will never be able to reverse those trends.” Together we can do those things, reverse those trends, make life good again!
1. The loss of “luster” in transplantation.2. Workforce problems in nephrology due to lack of appeal to young people/potential trainees worldwide.
3. Technological unemployment in medicine due to replacement of human workers by machines.
![Page 15: Kim Solez Transition transplant path to tissue engineering path new banff](https://reader036.fdocuments.us/reader036/viewer/2022081520/587f6d081a28ab9b398b72e7/html5/thumbnails/15.jpg)
Nephrologists & Renal Pathologists May Be Only People Still Employed in 2045!
![Page 16: Kim Solez Transition transplant path to tissue engineering path new banff](https://reader036.fdocuments.us/reader036/viewer/2022081520/587f6d081a28ab9b398b72e7/html5/thumbnails/16.jpg)
Banff Classification of Kidney Transplant Pathology
Histologic criteria for the diagnosis of rejection and other conditions in the transplanted kidney, began 1991, updated and expanded every two years in consensus meeting.
![Page 17: Kim Solez Transition transplant path to tissue engineering path new banff](https://reader036.fdocuments.us/reader036/viewer/2022081520/587f6d081a28ab9b398b72e7/html5/thumbnails/17.jpg)
Banff Lesion Scoring: Sign of Educated Tx Pathologist
imprimatur 1. The formula (=‘let it be printed’), signed by an official authorizing printing of a book;hence as sb. an official license to print.
The Oxford English Dictionary (2nd. ed.)Banff lesion scoring: g cg i ci t ct v cv ah mm ptc C4d
![Page 18: Kim Solez Transition transplant path to tissue engineering path new banff](https://reader036.fdocuments.us/reader036/viewer/2022081520/587f6d081a28ab9b398b72e7/html5/thumbnails/18.jpg)
1991 First Conference 1993 First Kidney International publication 1995 Integration with CADI 1997 Integration with CCTT classification 1999 Second KI paper. Clinical practice guidelines. Implantation biopsies. 2001 Classification of antibody-mediated rejection: Regulatory agencies
participating 2003 Genomics focus, ptc cell accumulation scoring 2005 Gene chip analysis. Elimination of CAN, identification of chronic
antibody-mediated rejection. 2007 First meeting far from a town called “Banff” – La Coruna, Spain. 2009 Working groups. Meeting in Banff, Alberta, Canada 2013 Establishment of Banff Foundation for Allograft Pathology
BANFF Classification - Milestones
![Page 19: Kim Solez Transition transplant path to tissue engineering path new banff](https://reader036.fdocuments.us/reader036/viewer/2022081520/587f6d081a28ab9b398b72e7/html5/thumbnails/19.jpg)
Significance of ‘Banff papers’• More than 5,000 citations of the 14 Banff meeting reports• 977 Banff / Transplantation papers in PubMed• Banff 2003 meeting report (ABMR criteria) = most cited AJT
paper• 3 Banff meeting reports are among the top 4 cited AJT articles
![Page 20: Kim Solez Transition transplant path to tissue engineering path new banff](https://reader036.fdocuments.us/reader036/viewer/2022081520/587f6d081a28ab9b398b72e7/html5/thumbnails/20.jpg)
Tissue Engineering Pathology Added Soon!•
![Page 21: Kim Solez Transition transplant path to tissue engineering path new banff](https://reader036.fdocuments.us/reader036/viewer/2022081520/587f6d081a28ab9b398b72e7/html5/thumbnails/21.jpg)
The Banff ProcessConsensus communication in renal transplantation
a
The Banff lesions
g, i, t, v - score
The Banff communityPathologistsNephrologistsTx-SurgeonsLab-Medicine
established by
consensus in 1991
The Banff classificationCurrent consensus for diagnostics
moderatedBanff meetings
thesis-antithesis-synthesis
tentative
thresholds
participate
refinementBanff Working Groups
Feedback concerning weaknesses and strengths by results from independent research
New membersBiostaticiansMolecular Biologists“Omics”-specialists
Off-springsLiverPancreasLung, HeartCTA
![Page 22: Kim Solez Transition transplant path to tissue engineering path new banff](https://reader036.fdocuments.us/reader036/viewer/2022081520/587f6d081a28ab9b398b72e7/html5/thumbnails/22.jpg)
Organizational structure of the Banff Foundation For Allograft Pathology
Board of Trustees: K. Solez (Chair), L. Racusen, D. Glotz, J. Demetris, M. Mengel, M. Mihatsch, D. Seron
2015 Local Conference chair: Michael Mengel
Organ Steering committee Chairs: Composite tissues: Linda CendalesHeart : Patrick BrunevalKidney: Mark HaasLiver: Jake DemetrisLung: William Wallace and Carol FarverPancreas: Cinthia Drachenberg
Banff Working Group (BWG) Leads: Molecular transplantation pathology: Michael Mengel, Banu SisIsolated v-lesions: Banu Sis, Ed KrausQuality assurance in transplantation diagnostics: Michael Mengel and Parmjeet RandhawaC4d-negative ABMR: Mark Haas, Banu Sis, Alexandre LoupyFibrosis scoring: Robert Colvin, Brad Farris, Michael MengelDigital Pathology in Transplantation: Jake Demetris
2015 Scientific program committee: Alex Loupy (Chair)Mark Haas, Banu Sis, Kathryn Tinkham, Candice Rofousse, Chris Bellamy, Lynn Cornell, Carmen LeFaucheurComposite tissues: Linda CendalesHeart : Patrick BrunevalLiver: Jake DemetrisLung: William Wallace and Carol FarverPancreas/Islets: Cinthia Drachenberg and John Papadimitriou
Secretary/Treasurer: Michael Mengel
funding
collaboration
reports to
reports to
collaboration
collaboration
reports to
collaborationprogress reports to Budged
proposal and accountability for meeting costs
support
![Page 23: Kim Solez Transition transplant path to tissue engineering path new banff](https://reader036.fdocuments.us/reader036/viewer/2022081520/587f6d081a28ab9b398b72e7/html5/thumbnails/23.jpg)
BANFF Conferences On Allograft Pathology 1991-Forever?
![Page 24: Kim Solez Transition transplant path to tissue engineering path new banff](https://reader036.fdocuments.us/reader036/viewer/2022081520/587f6d081a28ab9b398b72e7/html5/thumbnails/24.jpg)
![Page 25: Kim Solez Transition transplant path to tissue engineering path new banff](https://reader036.fdocuments.us/reader036/viewer/2022081520/587f6d081a28ab9b398b72e7/html5/thumbnails/25.jpg)
The World is Changing Rapidly!
![Page 26: Kim Solez Transition transplant path to tissue engineering path new banff](https://reader036.fdocuments.us/reader036/viewer/2022081520/587f6d081a28ab9b398b72e7/html5/thumbnails/26.jpg)
The World is Changing Rapidly!
![Page 27: Kim Solez Transition transplant path to tissue engineering path new banff](https://reader036.fdocuments.us/reader036/viewer/2022081520/587f6d081a28ab9b398b72e7/html5/thumbnails/27.jpg)
The World is Changing Rapidly!
![Page 28: Kim Solez Transition transplant path to tissue engineering path new banff](https://reader036.fdocuments.us/reader036/viewer/2022081520/587f6d081a28ab9b398b72e7/html5/thumbnails/28.jpg)
The World is Changing Rapidly!
![Page 29: Kim Solez Transition transplant path to tissue engineering path new banff](https://reader036.fdocuments.us/reader036/viewer/2022081520/587f6d081a28ab9b398b72e7/html5/thumbnails/29.jpg)
Perfused 7 days without oxygen or nutrients! Of course no nuclei seen!
![Page 30: Kim Solez Transition transplant path to tissue engineering path new banff](https://reader036.fdocuments.us/reader036/viewer/2022081520/587f6d081a28ab9b398b72e7/html5/thumbnails/30.jpg)
Canadian Data on Public Interest in Regenerative Medicine
![Page 31: Kim Solez Transition transplant path to tissue engineering path new banff](https://reader036.fdocuments.us/reader036/viewer/2022081520/587f6d081a28ab9b398b72e7/html5/thumbnails/31.jpg)
The Technological Singularity
![Page 32: Kim Solez Transition transplant path to tissue engineering path new banff](https://reader036.fdocuments.us/reader036/viewer/2022081520/587f6d081a28ab9b398b72e7/html5/thumbnails/32.jpg)
Podocytes go wandering into the interstitium! Song et al.
![Page 33: Kim Solez Transition transplant path to tissue engineering path new banff](https://reader036.fdocuments.us/reader036/viewer/2022081520/587f6d081a28ab9b398b72e7/html5/thumbnails/33.jpg)
Many problems with stem cell generate organs not being discussed. Do not exclude yourself from the action in this area!
![Page 34: Kim Solez Transition transplant path to tissue engineering path new banff](https://reader036.fdocuments.us/reader036/viewer/2022081520/587f6d081a28ab9b398b72e7/html5/thumbnails/34.jpg)
Many problems with stem cell generate organs not being discussed. Need to get those conversations to happen.
The recellularized organ clots like crazy, impossible to regenerate more than 80% of endothelial surface. Artificial heparized surface not fenestrated. Cell traffic abnormal.
Hard to get right types of cells to right places. Podocytes seems to be terminally differentiated cells,
when attempt to culture them they turn into different type of cell.
Kidney progenitor stem cell difficult to identify, kidney work has lagged behind.
Easy to make stem cell generated kidneys that lack loop of Henle. Could produce lethal polyuria. What is “function”?
Many old fashioned questions of physiology about how the stem cell generated organ works, not just true for kidney, true for every organ.
![Page 35: Kim Solez Transition transplant path to tissue engineering path new banff](https://reader036.fdocuments.us/reader036/viewer/2022081520/587f6d081a28ab9b398b72e7/html5/thumbnails/35.jpg)
Banff Foundation for Allograft Pathology and Banff Meetings Must Adapt to Future Changes in Field of Transplantation
Transplant pathologists will also become tissue engineering pathologists, pathologists who analyse organs grown from stem cells. This is not something beyond us, we can adapt to a work life that includes stem cells.. Someone needs to cross the disciplines,
![Page 36: Kim Solez Transition transplant path to tissue engineering path new banff](https://reader036.fdocuments.us/reader036/viewer/2022081520/587f6d081a28ab9b398b72e7/html5/thumbnails/36.jpg)
It is OK to Allow the Natural Resistance to Change and Nostalgia for the Past to Motivate You!
Many of the questions that need to be posed about stem cell generated organs are old fashioned questions, intact nephron hypothesis, cell regeneration, stunned myocardium, contraction band necrosis etc. Use your nostalgia! Stimulate conversations between stem cell researchers and transplant physicians.
![Page 37: Kim Solez Transition transplant path to tissue engineering path new banff](https://reader036.fdocuments.us/reader036/viewer/2022081520/587f6d081a28ab9b398b72e7/html5/thumbnails/37.jpg)
Beginning at the Very Beginning! “We are at the very beginning of time for the
human race. It is not unreasonable that we grapple with problems. But there are tens of thousands of years in the future. Our responsibility is to do what we can, learn what we can, improve the solutions, and pass them on.” - Richard P. Feynman, (1918-1988) Physicist, Nobel Prize Winner
"The sense of the future is behind all good policies. Unless we have it, we can give nothing either wise or decent to the world." - Snow CP, (1905-1980) Novelist and Philosopher.
"To a large extent, the future lies before us like a vast wilderness of unexplored reality. The God who created and sustained the evolving universe through eons of progress and development has not placed our generation at the tag end of the creative process. God has placed us at a new beginning. We are here for the future." - Sir John Templeton (1912-2008 ), Financial Analyst
![Page 38: Kim Solez Transition transplant path to tissue engineering path new banff](https://reader036.fdocuments.us/reader036/viewer/2022081520/587f6d081a28ab9b398b72e7/html5/thumbnails/38.jpg)
Beginning at the Very Beginning!
Like 1851 when the first International Classification of Diseases was presented in the Grand Exhibition of Technology at London’s Crystal Palace
Emphasis was on cause of death
![Page 39: Kim Solez Transition transplant path to tissue engineering path new banff](https://reader036.fdocuments.us/reader036/viewer/2022081520/587f6d081a28ab9b398b72e7/html5/thumbnails/39.jpg)
Classification focus is on sustaining life. Native and transplanted organ diseases can also
occur in tissue engineered organs. The classification focus of the new pathology
discipline of Regenerative Medicine/Tissue Engineering Pathology is exactly the opposite of traditional classification of disease which starts with causes of death. In Regenerative Medicine/Tissue Engineering Pathology the emphasis is on the degree of normality necessary to sustain life:
Normal, Abnormalities of unknown functional significance, Abnormalities which will impair the main functions
of the organ, Abnormalities leading to severe organ dysfunction
where function may not be great enough to sustain life.
![Page 40: Kim Solez Transition transplant path to tissue engineering path new banff](https://reader036.fdocuments.us/reader036/viewer/2022081520/587f6d081a28ab9b398b72e7/html5/thumbnails/40.jpg)
Song et al. Interstitium, vessels, and glomeruli with missing cells. Disordered tubule formation with multiple interconnecting lumina of differing sizes. “Can you really call this a kidney?” (Yes!)
![Page 41: Kim Solez Transition transplant path to tissue engineering path new banff](https://reader036.fdocuments.us/reader036/viewer/2022081520/587f6d081a28ab9b398b72e7/html5/thumbnails/41.jpg)
Song et al. In addition to missing cells and disordered structures,you have cells in the wrong places. Podocytes in the interstitium.
![Page 42: Kim Solez Transition transplant path to tissue engineering path new banff](https://reader036.fdocuments.us/reader036/viewer/2022081520/587f6d081a28ab9b398b72e7/html5/thumbnails/42.jpg)
Focus of Tissue Engineering Pathology The focus of tissue engineering pathology will
shift to the question: “Is this organ structurally intact enough to function safely and adequately in the recipient?” Using the kidney as an example, the specific questions become: (Images by Korey Fung)
1. Are there too many missing cells, distorted structures for the organ to function adequately?
![Page 43: Kim Solez Transition transplant path to tissue engineering path new banff](https://reader036.fdocuments.us/reader036/viewer/2022081520/587f6d081a28ab9b398b72e7/html5/thumbnails/43.jpg)
Focus of Tissue Engineering Pathology The focus of tissue engineering pathology will
shift to the question: “Is this organ structurally intact enough to function safely and adequately in the recipient?” Using the kidney as an example, the specific questions become: (Images by Korey Fung)
2. Are there too many cells in the wrong places (e.g. podocytes in the interstitium)
![Page 44: Kim Solez Transition transplant path to tissue engineering path new banff](https://reader036.fdocuments.us/reader036/viewer/2022081520/587f6d081a28ab9b398b72e7/html5/thumbnails/44.jpg)
Focus of Tissue Engineering Pathology (Images by Korey Fung) 3. Are there missing/distorted structural
elements that represent a risk to the patient? (missing loops of Henle causing lethal polyuria)
![Page 45: Kim Solez Transition transplant path to tissue engineering path new banff](https://reader036.fdocuments.us/reader036/viewer/2022081520/587f6d081a28ab9b398b72e7/html5/thumbnails/45.jpg)
Focus of Tissue Engineering Pathology Using the kidney as an example, the specific
questions become: 4. Is there too much endothelial disruption for the organ to be properly perfused? 5. What are the risks of neoplastic
transformation?
Classification categories should be not one-off, but reproducible, generalizable.
Tissue engineering pathology has been up to now really dull, since most reports were of scaffolds with no inflammatory reaction "Move along, nothing to see here" pathology, but from today becomes really exciting with novel morphological changes and lives hanging in the balance!
![Page 46: Kim Solez Transition transplant path to tissue engineering path new banff](https://reader036.fdocuments.us/reader036/viewer/2022081520/587f6d081a28ab9b398b72e7/html5/thumbnails/46.jpg)
Khouloud Saliba and I Presented These Ideas at TERMIS (Regenerative Medicine) Meeting in San Diego Dec. 11-14, 2016.
![Page 47: Kim Solez Transition transplant path to tissue engineering path new banff](https://reader036.fdocuments.us/reader036/viewer/2022081520/587f6d081a28ab9b398b72e7/html5/thumbnails/47.jpg)
Met Astgik Petrosyan Who Has Written About the Many Additional Variables Which Will Add Complexity to New Banff Classification
Decellularized Renal Matrix and Regenerative Medicine of the Kidney: A Different Point of View Petrosyan Astgik, … and Perin Laura. Tissue Engineering Part B: Reviews. May 2016, 22(3): 183-192.
A Step Towards Clinical Application of Acellular Matrix: A Clue from Macrophage Polarization. Petrosyan A, …Perin L. Matrix Biol. 2016 Aug 26. pii: S0945-053X(16)30133-0.
![Page 48: Kim Solez Transition transplant path to tissue engineering path new banff](https://reader036.fdocuments.us/reader036/viewer/2022081520/587f6d081a28ab9b398b72e7/html5/thumbnails/48.jpg)
Astgik Petrosyan Variables Will Necessitate AI Approaches to New Banff Classification!
![Page 49: Kim Solez Transition transplant path to tissue engineering path new banff](https://reader036.fdocuments.us/reader036/viewer/2022081520/587f6d081a28ab9b398b72e7/html5/thumbnails/49.jpg)
Originally we had mule deer poking their heads into the
meeting rooms. Now we have real data complexity but
outcome should be very good for patients. We’ve come a long
way!